126 related articles for article (PubMed ID: 35254487)
21. Methylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with myelodysplastic syndrome.
Lin J; Yao DM; Qian J; Wang YL; Han LX; Jiang YW; Fei X; Cen JN; Chen ZX
Leuk Res; 2008 Oct; 32(10):1541-5. PubMed ID: 18367246
[TBL] [Abstract][Full Text] [Related]
22. 5'CpG island hypermethylation and aberrant transcript splicing both contribute to the inactivation of the FHIT gene in resected non-small cell lung cancer.
Tzao C; Tsai HY; Chen JT; Chen CY; Wang YC
Eur J Cancer; 2004 Sep; 40(14):2175-83. PubMed ID: 15341994
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity.
Cantor JP; Iliopoulos D; Rao AS; Druck T; Semba S; Han SY; McCorkell KA; Lakshman TV; Collins JE; Wachsberger P; Friedberg JS; Huebner K
Int J Cancer; 2007 Jan; 120(1):24-31. PubMed ID: 17019711
[TBL] [Abstract][Full Text] [Related]
24. Molecular and epigenetic analysis of the fragile histidine triad tumour suppressor gene in equine sarcoids.
Strazzullo M; Corteggio A; Altamura G; Francioso R; Roperto F; D'Esposito M; Borzacchiello G
BMC Vet Res; 2012 Mar; 8():30. PubMed ID: 22424615
[TBL] [Abstract][Full Text] [Related]
25. Methylation status of the fragile histidine triad and E-cadherin genes in plasma of cervical cancer patients.
Ren CC; Miao XH; Yang B; Zhao L; Sun R; Song WQ
Int J Gynecol Cancer; 2006; 16(5):1862-7. PubMed ID: 17009983
[TBL] [Abstract][Full Text] [Related]
26. DNA methylome analysis identifies epigenetic silencing of FHIT as a determining factor for radiosensitivity in oral cancer: an outcome-predicting and treatment-implicating study.
Lin HY; Hung SK; Lee MS; Chiou WY; Huang TT; Tseng CE; Shih LY; Lin RI; Lin JM; Lai YH; Chang CB; Hsu FC; Chen LC; Tsai SJ; Su YC; Li SC; Lai HC; Hsu WL; Liu DW; Tai CK; Wu SF; Chan MW
Oncotarget; 2015 Jan; 6(2):915-34. PubMed ID: 25460508
[TBL] [Abstract][Full Text] [Related]
27. Nicotine induces the fragile histidine triad methylation in human esophageal squamous epithelial cells.
Soma T; Kaganoi J; Kawabe A; Kondo K; Imamura M; Shimada Y
Int J Cancer; 2006 Sep; 119(5):1023-7. PubMed ID: 16570269
[TBL] [Abstract][Full Text] [Related]
28. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
[TBL] [Abstract][Full Text] [Related]
29. Aberrations of the FHIT gene and Fhit protein in canine lymphoma cell lines.
Hiraoka H; Minami K; Kaneko N; Shimokawa Miyama T; Okamura Y; Mizuno T; Okuda M
J Vet Med Sci; 2009 Jun; 71(6):769-77. PubMed ID: 19578286
[TBL] [Abstract][Full Text] [Related]
30. Folate deficiency and FHIT hypermethylation and HPV 16 infection promote cervical cancerization.
Bai LX; Wang JT; Ding L; Jiang SW; Kang HJ; Gao CF; Chen X; Chen C; Zhou Q
Asian Pac J Cancer Prev; 2014; 15(21):9313-7. PubMed ID: 25422218
[TBL] [Abstract][Full Text] [Related]
31. Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer.
Iliopoulos D; Guler G; Han SY; Johnston D; Druck T; McCorkell KA; Palazzo J; McCue PA; Baffa R; Huebner K
Oncogene; 2005 Feb; 24(9):1625-33. PubMed ID: 15674328
[TBL] [Abstract][Full Text] [Related]
32. [Methylation status of FHIT gene in plasma and expression of FHIT gene in cancer tissue of cervical cancer patients].
Ren CC; Miao XH; Yang B; Zhao L; Sun R; Song WQ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Oct; 23(5):565-7. PubMed ID: 17029211
[TBL] [Abstract][Full Text] [Related]
33. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
[TBL] [Abstract][Full Text] [Related]
34. Frequent epigenetic silencing of the FHIT gene in penile squamous cell carcinomas.
Yanagawa N; Osakabe M; Hayashi M; Tamura G; Motoyama T
Virchows Arch; 2008 Apr; 452(4):377-82. PubMed ID: 18299890
[TBL] [Abstract][Full Text] [Related]
35. [Influence of folate on fragile histidine triad gene expression, cell proliferation and apoptosis in cervical cancer cell lines].
Gao C; Kang H; Bai L; Ding L; Xu J; Wu T; Bai L; Wang J
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 May; 35(5):569-72. PubMed ID: 25059370
[TBL] [Abstract][Full Text] [Related]
36. The Fragile Histidine Triad gene and breast cancer.
Yang Q; Yoshimura G; Sakurai T; Kakudo K
Med Sci Monit; 2002 Jul; 8(7):RA140-4. PubMed ID: 12118213
[TBL] [Abstract][Full Text] [Related]
37. Reduced FHIT expression is associated with mismatch repair deficient and high CpG island methylator phenotype colorectal cancer.
Al-Temaimi RA; Jacob S; Al-Ali W; Thomas DA; Al-Mulla F
J Histochem Cytochem; 2013 Sep; 61(9):627-38. PubMed ID: 23797051
[TBL] [Abstract][Full Text] [Related]
38. Analysis of FHIT gene methylation in egyptian breast cancer women: association with clinicopathological features.
Zaki SM; Abdel-Azeez HA; El Nagar MR; Metwally KA; S Ahmed MM
Asian Pac J Cancer Prev; 2015; 16(3):1235-9. PubMed ID: 25735361
[TBL] [Abstract][Full Text] [Related]
39. FHIT: doubts are clear now.
Wali A
ScientificWorldJournal; 2010 Jun; 10():1142-51. PubMed ID: 20563537
[TBL] [Abstract][Full Text] [Related]
40. Mutational and promoter hypermethylation status of FHIT gene in breast cancer patients of Kashmir.
Syeed N; Husain SA; Sameer AS; Chowdhri NA; Siddiqi MA
Mutat Res; 2011 Feb; 707(1-2):1-8. PubMed ID: 21095196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]